• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets

tetano

Editor, Senior Moderator
Virology. 2015 Jul 2;484:305-312. doi: 10.1016/j.virol.2015.06.020. [Epub ahead of print]
[h=1]Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.[/h] Belser JA[SUP]1[/SUP], Maines TR[SUP]2[/SUP], Creager HM[SUP]3[/SUP], Katz JM[SUP]2[/SUP], Tumpey TM[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Ocular exposure to influenza virus represents an alternate route of virus entry capable of establishing a respiratory infection in mammals, but the effectiveness of currently available antiviral treatments to limit virus replication within ocular tissue or inhibit virus spread from ocular sites to the respiratory tract is poorly understood. Using an inoculation method that delivers an aerosol inoculum exclusively to the ocular surface, we demonstrate that oral oseltamivir administration following ocular-only aerosol inoculation with multiple avian and human influenza viruses protected ferrets from a fatal and systemic infection, reduced clinical signs and symptoms of illness, and decreased virus transmissibility to susceptible contacts when a respiratory infection was initiated. The presence of oseltamivir further inhibited influenza virus replication in primary human corneal epithelial cells. These findings provide critical experimental evidence supporting the use of neuraminidase inhibitors during outbreaks of influenza virus resulting in ocular disease or following ocular exposure.
Published by Elsevier Inc.


[h=4]KEYWORDS:[/h] Aerosol; Antiviral; Ferret model; Influenza virus; Oseltamivir (Tamiflu); Transmission

PMID: 26142497 [PubMed - as supplied by publisher]
 
Back
Top Bottom